It’s baseball season. Grand slams don’t come that often, and neither do investments that we think have the potential to return to us 4x our investment… But they do come around from time to time. Every team has hope, except […]
We discovered what we fancy one of our best speculative plays in a long time. We see the potential for a ten-bagger in the cards over the next year. We are banking on being able to cash in on early […]
On the heels of a new relationship with IBM (NYSE:IBM), we found a stock that we think has a great chance of being acquired for a price 400% to 500% above its current price. We wanted to hold off on […]
President Trump’s promises of tax reform, business deregulation and infrastructure spending are not the only catalysts driving micro-cap and small-cap stocks. The current micro-cap environment is ripe for shareholder activism and can help expand the valuation of quality “growth + value” […]
In July of 2016, several media outlets, as well as a top activist publication, contacted us. They wanted to know more about the role we were taking to prevent American Securities (“PE Firm”), a private equity firm from “stealing” public […]
Last Thursday, April 13, 2017, we published our findings on why we are very bearish on Great Basin Scientific (OTC:GBSN) (GBSND), a company that describes itself as a molecular diagnostics company. We commented on what we perceive as a series of bad […]
After a successful swing trade alert issued on Highpower International Inc (NASDAQ:HPJ) which climbed 75% in seven trading days, our China team is hot on the trail on new Information Arbitrage alerts related to two U.S. listed China Stocks. The […]
A Stock Peter Lynch Would Love As a preacher of “invest in what you know”, Peter Lynch would love this pet products company engaged in developing, manufacturing and marketing products for the retail pet business. We think the company is one of those […]